OraSure Technologies Sees Unusually High Options Volume (NASDAQ:OSUR)

by · The Markets Daily

OraSure Technologies, Inc. (NASDAQ:OSUR – Get Free Report) was the recipient of unusually large options trading on Monday. Investors purchased 7,517 call options on the company. This is an increase of approximately 1,165% compared to the typical volume of 594 call options.

OraSure Technologies Stock Up 0.2%

OSUR opened at $4.47 on Wednesday. The stock’s 50 day moving average price is $3.68 and its two-hundred day moving average price is $3.12. The firm has a market capitalization of $307.76 million, a P/E ratio of -4.29 and a beta of 1.02. OraSure Technologies has a 12-month low of $2.08 and a 12-month high of $4.58.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of OraSure Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, June 4th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average target price of $3.00.

Read Our Latest Research Report on OraSure Technologies

Insider Transactions at OraSure Technologies

In related news, Director Steven Kyle Boyd purchased 25,000 shares of the stock in a transaction on Thursday, May 14th. The shares were bought at an average price of $2.99 per share, for a total transaction of $74,750.00. Following the completion of the acquisition, the director directly owned 113,462 shares in the company, valued at approximately $339,251.38. This trade represents a 28.26% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 4.70% of the stock is owned by insiders.

Institutional Investors Weigh In On OraSure Technologies

Several hedge funds and other institutional investors have recently modified their holdings of OSUR. Quadrature Capital Ltd acquired a new position in OraSure Technologies during the 4th quarter valued at $28,000. Prudential Financial Inc. bought a new position in shares of OraSure Technologies during the 2nd quarter worth about $31,000. Diversify Wealth Management LLC acquired a new position in shares of OraSure Technologies during the first quarter valued at about $36,000. Amundi acquired a new position in shares of OraSure Technologies during the first quarter valued at about $47,000. Finally, SG Americas Securities LLC raised its position in shares of OraSure Technologies by 77.7% during the fourth quarter. SG Americas Securities LLC now owns 19,748 shares of the medical instruments supplier’s stock valued at $48,000 after buying an additional 8,632 shares during the last quarter. Institutional investors and hedge funds own 93.50% of the company’s stock.

About OraSure Technologies

(Get Free Report)

OraSure Technologies, Inc is a Bethlehem, Pennsylvania–based diagnostic and medical device company specializing in the development, manufacture and commercialization of point-of-care and self-testing products. Founded in 1988, OraSure has built a portfolio of oral fluid and other non-invasive specimen collection technologies that support the detection of infectious diseases, drugs of abuse, and health and wellness biomarkers.

The company’s flagship product, the OraQuick® rapid HIV test, was the first Food and Drug Administration–approved over-the-counter oral fluid test for the detection of HIV-1/2 antibodies.

Read More